CCL2 and hepatocellular carcinoma: Analysis of plasma cytokine concentrations in patients with end-stage ALD without HCC (GG genotype vs. CC/CG genotype) revealed that GG carriers had significantly higher concentrations of CCL2 (212.6 [135.9–264.9] pg/mL) compared to CC/CG carriers (141.3 [104.1–201.6] pg/mL, p = 0.002, Mann–Whitney).